![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories Summit (formerly Vastox) has signed a $450,000 (€312,000) deal with one of the world's top 5 pharma firms to enable it to use Summit's zebrafish-platform in its drug safety programme... Read Another safety scare for Roche In another safety concern over a long-approved drug, Roche has been forced to add new warnings to its anti-transplant rejection drug CellCept (mycophenolate mofetil (MMF)) amid the news that it is associated with... Read Takeda sleeping drug takes 'Worst Product Award' Japanese pharma firm Takeda beat off strong competition from the likes of Coca-Cola to take home the dubious honour of Consumer International's 'Worst Product' award thanks to its sleeping pill ad... Read Thermo continues fishing in India Thermo Fisher Scientific continues to fish for new opportunities in India and has begun setting up a new clinical services base in the country... Read Peptide chatter encourages bacteria to commit suicide Scientists have discovered a peptide that enables bacteria to chat to one another, and can induce them to commit suicide, opening the door to new antibiotics... Read |
|||||||||||||||||
All News Headlines for: October | September | August |
|||||||||||||||||
![]() Have you got problems with aching hands in your lab? Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more..... Click Here | |||||||||||||||||
|
Related Industry News Bayer banishes high dose MS drug Bayer Schering Pharma this week announced that it has scrapped plans to introduce a double-dose version of its top-selling multiple sclerosis (MS) drug Betaferon (interferon beta-1b) by the end of the year following... Read Explosions at two pharma plants Two pharmaceutical companies have faced explosions at their plants in the last week, local media reported... Read Applied Biosystems and Celera return first quarter profits Applied Biosystems (ABI) saw 5 per cent revenue growth during its first quarter of fiscal 2008 as sister company Celera posted revenue growth of 57 per cent... Read Survey asks: what to do about counterfeit drugs? Action should be taken to curb the counterfeit drug trade, but not via legal intervention, the results of a European survey say... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||